IGF-1 LR3 is a modified analog of insulin-like growth factor-1, widely studied in the research community for its extended stability and interaction with cellular growth and signaling pathways. Engineered with a longer half-life compared to native IGF-1, IGF-1 LR3 is commonly utilized in laboratory investigations focused on cellular development and receptor-mediated processes.